SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-039253
Filing Date
2020-03-27
Accepted
2020-03-27 08:01:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a20-13830_1424b5.htm 424B5 10044
2 GRAPHIC g138301bai001.jpg GRAPHIC 2305
3 GRAPHIC g138301bai002.jpg GRAPHIC 4062
  Complete submission text file 0001104659-20-039253.txt   20303
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-214882 | Film No.: 20748076
SIC: 2835 In Vitro & In Vivo Diagnostic Substances